Potential Sciences is a healthcare technology company focused on accelerating drug discovery through artificial intelligence, computational biology, and advanced scientific research. The company builds a GPU-native quantum chemistry simulation engine for molecular modeling, combining high-fidelity electronic structure methods with machine learning to tackle compute bottlenecks in AI-driven drug discovery.

Its scientific computing software supports density functional theory (DFT) workflows, molecular property prediction, and the generation of synthetic datasets at scale. Operating at the intersection of machine learning hardware acceleration, computational chemistry, and physical sciences simulation, the company targets pharmaceutical and biotech R&D organizations as well as computational chemistry and materials modeling teams.